Cidara Therapeutics, Inc.
New Filing
CIK: 0001610618·Biotechnology·DELAWARE·Filed: May 30, 2018
Total Offering
$1,874,999
Amount Sold
$1,562,499
Investors
16
First Sale
May 23, 2018
Offering Details
- Type
- Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Jeffrey Stein | Related Person |
| Daniel D. Burgess | Related Person |
| Scott M Rocklage | Related Person |
| Theodore R. Schroeder | Related Person |
| Robert J Perez | Related Person |
| Timothy R Franson | Related Person |
| Matthew Onaitis | Related Person |
| Taylor Sandison | Related Person |
| Chrysa Mineo | Related Person |
Company
SEC Filing
0001736945-18-000006
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free